Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.
复制标题

DOI:
10.1007/s11892-018-1101-6
复制
发表时间:
2018-10-17
影响因子:
4.2
通讯作者:
Eckel RH
Eckel RH
中科院分区:
医学2区
文献类型:
--
作者:
Bjornstad P;Eckel RH

文献摘要

参考文献

被引文献

相似文献

胰岛素抵抗(IR)在血脂异常的发病机制中起重要作用。本文综述了胰岛素抵抗和血脂异常在糖尿病患者和非糖尿病患者之间复杂的相互作用。IR通过多种机制影响甘油三酯、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和极低密度脂蛋白胆固醇(VLDL-C)的代谢。胰岛素增敏治疗(包括双胍类和噻唑烷二酮类)的试验在糖尿病患者和非糖尿病患者中提供了不一致的降脂结果。在这篇综述中,我们着重于IR和血脂异常之间的病理生理学相互作用,并概括了胰岛素增敏试验中的脂质和脂蛋白数据。需要进一步研究阐明IR和血脂异常之间的相互关系,以更好地靶向这些重要的心血管疾病危险因素。
Insulin resistance (IR) is recognized to play an important role in the pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR and dyslipidemia in people with and without diabetes. IR impacts the metabolism of triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and very low-density lipoprotein cholesterol (VLDL-C) by several mechanisms. Trials with insulin sensitizing therapies, including biguanides and thiazolidinediones, have provided inconsistent results on lipid lowering in people with and without diabetes. In this review, we focus on the pathophysiological interplay between IR and dyslipidemia and recapitulate lipid and lipoprotein data from insulin sensitizing trials. Further research elucidating the reciprocal relationship between IR and dyslipidemia is needed to better target these important risk factors for cardiovascular disease.
DOI: 10.1016/j.amjcard.2015.07.020
发表时间: 2015-10-01
影响因子: 2.8
作者:
Bjornstad, Petter;Eckel, Robert H.;Snell-Bergeon, Janet K.
通讯作者: Snell-Bergeon, Janet K.
DOI: 10.1093/eurheartj/ehr112
发表时间: 2011-06
影响因子: 39.3
作者:
Chapman MJ;Ginsberg HN;Amarenco P;Andreotti F;Borén J;Catapano AL;Descamps OS;Fisher E;Kovanen PT;Kuivenhoven JA;Lesnik P;Masana L;Nordestgaard BG;Ray KK;Reiner Z;Taskinen MR;Tokgözoglu L;Tybjærg-Hansen A;Watts GF;European Atherosclerosis Society Consensus Panel
通讯作者: European Atherosclerosis Society Consensus Panel
DOI: 10.2337/diabetes.54.12.3458
发表时间: 2005-12-01
期刊: DIABETES
影响因子: 7.7
作者:
Boden, G;She, PX;Ruderman, N
通讯作者: Ruderman, N
DOI: 10.1053/j.ajkd.2010.10.007
发表时间: 2011-01-01
影响因子: 13.2
作者:
Collins, Allan J.;Foley, Robert N.;Agodoa, Lawrence
通讯作者: Agodoa, Lawrence
DOI: 10.1111/pedi.12277
发表时间: 2016-06-01
期刊: PEDIATRIC DIABETES
影响因子: 3.4
作者:
Cree-Green, Melanie;Maahs, David M.;Nadeau, Kristen J.
通讯作者: Nadeau, Kristen J.